InsidersTradesSigma
Explore the detailed record of transactions filed by Renée Aguiar Lucander, 首席执行官. Officer active across 2 companies, notably Hansa Biopharma AB. Cumulatively, 2 reports have been published. History available since 27 July 2025. The latest transaction was disclosed on 28 July 2025 (Purchase). Regulator: FIN-FSA. All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
RENÉE AGUIAR LUCANDER is the CEO of Hansa Biopharma AB. She is responsible for managing the company and executing its strategy in the biopharmaceutical sector.